Biotech · Private company
Octapharma
Track this companyFree. Adds Octapharma to your Dealase workspace and tells you when its record changes.
Clinical trials2512 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline23
- AtenativPhase 3 · Congenital Antithrombin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Beriplex P/N (Kcentra)Phase 3 · Significant Bleeding RiskClinicalTrials.gov · fetched Nov 12, 2026
- CUTAQUIGPhase 3 · Primary Immune Deficiency DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Frozen Plasma Product, HumanPhase 3 · Bleeding Cardiac Surgery PatientsClinicalTrials.gov · fetched Nov 12, 2026
- Human plasma derived antithrombinPhase 3 · Acquired Antithrombin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- NewnormPhase 3 · Primary Immune DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- OCTA-C1-INHPhase 3 · Acute Hereditary Angio EdemaClinicalTrials.gov · fetched Nov 12, 2026
- Octagam 10%Phase 3 · Covid-19ClinicalTrials.gov · fetched Nov 12, 2026
- OctaplexPhase 3 · Significant Bleeding RiskClinicalTrials.gov · fetched Nov 12, 2026
- OctaplexPhase 3 · Acute Major BleedingClinicalTrials.gov · fetched Nov 12, 2026
- OctaplexPhase 3 · Bleeding Cardiac Surgery PatientsClinicalTrials.gov · fetched Nov 12, 2026
- PanzygaPhase 3 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- PanzygaPhase 3 · Pediatric Chronic Inflammatory Demyelinating PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- PanzygaPhase 3 · Pediatric Acute-Onset Neuropsychiatric SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Panzyga, 10% Intravenous SolutionPhase 3 · HypogammaglobulinemiaClinicalTrials.gov · fetched Nov 12, 2026
- WilatePhase 3 · Von Willebrand DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- WilatePhase 3 · Von Willebrand DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BalfaxarVitamin K-Dependent Coagulation DefectClinicalTrials.gov · fetched Nov 12, 2026
- KcentraVitamin K-Dependent Coagulation DefectClinicalTrials.gov · fetched Nov 12, 2026
- NuwiqSevere Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- NuwiqHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- PanzygaChronic Immune ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- Von Willebrand Factor-Containing ProductVon Willebrand DiseasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent InfectionsPHASE3 · RECRUITING · started Jun 10, 2026ClinicalTrials.gov NCT07220915 · fetched Nov 12, 2026
- Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for SurgeryPHASE4 · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT05936580 · fetched Nov 12, 2026
- Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive ProcedureACTIVE_NOT_RECRUITING · started Feb 14, 2025ClinicalTrials.gov NCT06429787 · fetched Nov 12, 2026
- Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary BypassPHASE3 · RECRUITING · started Aug 21, 2024ClinicalTrials.gov NCT06096116 · fetched Nov 12, 2026
- Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema AttacksPHASE3 · RECRUITING · started Apr 30, 2024ClinicalTrials.gov NCT06361537 · fetched Nov 12, 2026
- Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis StudyPHASE4 · RECRUITING · started Nov 28, 2023ClinicalTrials.gov NCT05935358 · fetched Nov 12, 2026
- Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PatientsPHASE3 · RECRUITING · started Oct 1, 2023ClinicalTrials.gov NCT04929236 · fetched Nov 12, 2026
- Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac SurgeryPHASE3 · COMPLETED · started Nov 30, 2022ClinicalTrials.gov NCT05523297 · fetched Nov 12, 2026
- Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryPHASE3 · RECRUITING · started Jul 1, 2022ClinicalTrials.gov NCT04918173 · fetched Nov 12, 2026
- Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery PatientsPHASE4 · COMPLETED · started Oct 26, 2021ClinicalTrials.gov NCT04376762 · fetched Nov 12, 2026
- Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of AgePHASE3 · COMPLETED · started Sep 22, 2021ClinicalTrials.gov NCT04953884 · fetched Nov 12, 2026
- Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa InhibitorPHASE3 · TERMINATED · started Sep 1, 2021ClinicalTrials.gov NCT04867837 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency DiseasesPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 4, 2021ClinicalTrials.gov NCT04640142 · fetched Nov 12, 2026
- Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)PHASE3 · COMPLETED · started Jun 30, 2021ClinicalTrials.gov NCT04508530 · fetched Nov 12, 2026
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)PHASE3 · COMPLETED · started Oct 5, 2020ClinicalTrials.gov NCT04502030 · fetched Nov 12, 2026
- Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWDPHASE3 · COMPLETED · started Jun 18, 2020ClinicalTrials.gov NCT04052698 · fetched Nov 12, 2026
- Octagam 10% Therapy in COVID-19 Patients With Severe Disease ProgressionPHASE3 · COMPLETED · started Jun 1, 2020ClinicalTrials.gov NCT04400058 · fetched Nov 12, 2026
- Treatment of Hemophilia A Patients With FVIII InhibitorsRECRUITING · started Mar 17, 2020ClinicalTrials.gov NCT04023019 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)PHASE4 · TERMINATED · started Jan 21, 2020ClinicalTrials.gov NCT03866798 · fetched Nov 12, 2026
- Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency DiseasesPHASE3 · COMPLETED · started Oct 17, 2019ClinicalTrials.gov NCT03939533 · fetched Nov 12, 2026
- Von Willebrand Factor in Pregnancy (VIP) StudyRECRUITING · started Oct 12, 2019ClinicalTrials.gov NCT04146376 · fetched Nov 12, 2026
- Bleeding Incidence in VWD Patients Undergoing On-Demand TreatmentCOMPLETED · started Jun 25, 2019ClinicalTrials.gov NCT04053699 · fetched Nov 12, 2026
- Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A PatientsRECRUITING · started Feb 13, 2018ClinicalTrials.gov NCT03695978 · fetched Nov 12, 2026
- Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.PHASE3 · COMPLETED · started Jun 8, 2017ClinicalTrials.gov NCT02740335 · fetched Nov 12, 2026
- A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft RecipientsTERMINATED · started Jul 1, 2014ClinicalTrials.gov NCT02115503 · fetched Nov 12, 2026